InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Brandicourt Olivier. Officer active across 4 companies, notably BeiGene, Ltd.. Cumulatively, 9 filings have been recorded. History available since 5 June 2024. The latest transaction was disclosed on 20 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
BRANDICOURT OLIVIER is a declarant with 7 filings in total. The 7 sampled filings cover the period from 2024-06-07 to 2026-06-16, with buy volume of EUR 0 and sell volume of EUR 0. He is a director at BeOne Medicines Ltd., ALNYLAM PHARMACEUTICALS, INC., BeiGene, Ltd. and Vaxcyte, Inc., and the most common transaction nature is attribution.